Cargando…
Application of Molecular Modeling to Development of New Factor Xa Inhibitors
In consequence of the key role of factor Xa in the clotting cascade and absence of its activity in the processes that do not affect coagulation, this protein is an attractive target for development of new blood coagulation inhibitors. Factor Xa is more effective and convenient target for creation of...
Autores principales: | Sulimov, Vladimir B., Gribkova, Irina V., Kochugaeva, Maria P., Katkova, Ekaterina V., Sulimov, Alexey V., Kutov, Danil C., Shikhaliev, Khidmet S., Medvedeva, Svetlana M., Krysin, Michael Yu., Sinauridze, Elena I., Ataullakhanov, Fazoil I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592935/ https://www.ncbi.nlm.nih.gov/pubmed/26484350 http://dx.doi.org/10.1155/2015/120802 |
Ejemplares similares
-
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-ij]Quinolin-2(1H)-one as New Inhibitors of Factor Xa and Factor XIa
por: Novichikhina, Nadezhda, et al.
Publicado: (2020) -
New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture
por: Sulimov, Alexey, et al.
Publicado: (2022) -
New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation
por: Tashchilova, Anna, et al.
Publicado: (2022) -
New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation
por: Novichikhina, Nadezhda P., et al.
Publicado: (2023) -
Evaluation of Docking Target Functions by the Comprehensive Investigation of Protein-Ligand Energy Minima
por: Oferkin, Igor V., et al.
Publicado: (2015)